Interferon-Free Hepatitis C Tx Hits Snag
SEATTLE (MedPage Today) — Results in a hard-to-treat patient population have clouded the future of a closely watched agent that acts against hepatitis C directly.
SEATTLE (MedPage Today) — Results in a hard-to-treat patient population have clouded the future of a closely watched agent that acts against hepatitis C directly.
Comments are closed.
All rights reserved. © UK. Site Map | Contact us | About us | Contributors | Supporters | Terms & Conditions
This site complies with the HONcode standard for trustworthy health information: verify here.